Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,389
datasets available to search
ShareScore release 0.9.0
Dataset results
1,389 results for “Bladder cancer”
Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants
ClinicalTrials.gov study NCT02792192. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer
ClinicalTrials.gov study NCT00585689. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder
ClinicalTrials.gov study NCT02891161. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Instillation of Gemcitabine in Patients With Superficial Bladder Cancer
ClinicalTrials.gov study NCT00191477. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT04165317. IPD Sharing: YES. Countries: 14. Publications: 2.
A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT03498196. IPD Sharing: UNDECIDED. Countries: 1. Publications: 29.
S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
ClinicalTrials.gov study NCT00445601. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT01589094. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
ClinicalTrials.gov study NCT06138561. IPD Sharing: YES. Countries: 1. Publications: 4.
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1)
ClinicalTrials.gov study NCT02951767. IPD Sharing: Not stated. Countries: 8. Publications: 2.
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
ClinicalTrials.gov study NCT00238420. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Role of FDG-PET CT in the Management of Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT04053101. IPD Sharing: NO. Countries: 1. Publications: 1.
CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer
ClinicalTrials.gov study NCT03933826. IPD Sharing: YES. Countries: 1. Publications: 2.
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
ClinicalTrials.gov study NCT02177695. IPD Sharing: YES. Countries: 1. Publications: 3.
Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer
ClinicalTrials.gov study NCT01118351. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT01410565. IPD Sharing: Not stated. Countries: 2. Publications: 3.
Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer
ClinicalTrials.gov study NCT01827943. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Weekly Radiotherapy for Bladder Cancer
ClinicalTrials.gov study NCT01810757. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT00380029. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Tislelizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer
ClinicalTrials.gov study NCT04004221. IPD Sharing: YES. Countries: 2. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.